US pharma giant Pfizer will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Chicago-based pharma major AbbVie and privately-held San Diego biotech ADARx Pharmaceuticals have announced a collaboration ...

Fibrosis drug developer Tvardi Therapeutics has hit the ground running after completing its merger with troubled US biotech ...

UK-based Kaerus Bioscience, a biopharma created by European investment firm Medicxi for the development of therapeutics for ...

US biotech Cytokinetics has unveiled fresh Phase III data backing its heart drug aficamten, showing the treatment was more ...

San Diego, USA-based biotech Capricor Therapeutics (Nasdaq; CAPR) yesterday announced the appointment of Dr Michael Binks as ...

In a further bid to expand its already lucrative portfolio of metabolic and obesity medicines, Denmark’s Novo Nordisk (NOV: N ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Finnish biotech Tilt Biotherapeutics has raised $26 million (22.6 million euros) in a series B round to move its lead cancer ...

Representatives of Russian patent unions have sent an appeal to the Russian Scientific Center for Expertise of Medical ...

Danish CNS specialist Lundbeck (LUND: CO) today released first-quarter 2025 financials, along with a raised guidance for the ...